Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer

William L. Dahut, James L. Gulley, Philip M. Arlen, Yinong Liu, Katherine M. Fedenko, Seth M. Steinberg, John J. Wright, Howard Parnes, Clara C. Chen, Elizabeth Jones, Catherine E. Parker, W. Marston Linehan, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

303 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences